These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 25156678)

  • 21. Clostridium difficile infection: A brief update on emerging therapies.
    Goldberg EJ; Bhalodia S; Jacob S; Patel H; Trinh KV; Varghese B; Yang J; Young SR; Raffa RB
    Am J Health Syst Pharm; 2015 Jun; 72(12):1007-12. PubMed ID: 26025991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current treatment and epidemiology of Clostridium difficile infections].
    Dinh A; Bouchand F; Le Monnier A
    Rev Med Interne; 2015 Sep; 36(9):596-602. PubMed ID: 25772664
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Asempa TE; Nicolau DP
    Clin Interv Aging; 2017; 12():1799-1809. PubMed ID: 29123385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High frequency of nonadherence to Clostridium difficile treatment guidelines.
    McEllistrem MC; McGraw M; Sahud AG; Chan-Tompkins NH; Goswami R; Bhanot N
    South Med J; 2014 Sep; 107(9):597-9. PubMed ID: 25188627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology, diagnosis and treatment of Clostridium difficile infection.
    Bassetti M; Villa G; Pecori D; Arzese A; Wilcox M
    Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1405-23. PubMed ID: 23253319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
    Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridium difficile infections: do we know the real dimensions of the problem?
    Tattevin P; Buffet-Bataillon S; Donnio PY; Revest M; Michelet C
    Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S36-40. PubMed ID: 23664578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors predictive of severe Clostridium difficile infection depend on the definition used.
    Khanafer N; Barbut F; Eckert C; Perraud M; Demont C; Luxemburger C; Vanhems P
    Anaerobe; 2016 Feb; 37():43-8. PubMed ID: 26335160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridium difficile infection and inflammatory bowel disease.
    Cojocariu C; Stanciu C; Stoica O; Singeap AM; Sfarti C; Girleanu I; Trifan A
    Turk J Gastroenterol; 2014 Dec; 25(6):603-10. PubMed ID: 25599768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium difficile infection in children: a comprehensive review.
    Pant C; Deshpande A; Altaf MA; Minocha A; Sferra TJ
    Curr Med Res Opin; 2013 Aug; 29(8):967-84. PubMed ID: 23659563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multidisciplinary approach of Clostridium difficile infection].
    Pérez M; Hurtado AI; Couto I; Gutiérrez JM; Seoane L; Suárez JM; Galeiras R
    Rev Chilena Infectol; 2013 Apr; 30(2):165-85. PubMed ID: 23677156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and microbiological features of Clostridium difficile infections in France: the ICD-RAISIN 2009 national survey.
    Eckert C; Coignard B; Hebert M; Tarnaud C; Tessier C; Lemire A; Burghoffer B; Noel D; Barbut F;
    Med Mal Infect; 2013 Feb; 43(2):67-74. PubMed ID: 23498135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clostridium difficile: epidemiology, pathogenesis, management, and prevention of a recalcitrant healthcare-associated pathogen.
    Badger VO; Ledeboer NA; Graham MB; Edmiston CE
    JPEN J Parenter Enteral Nutr; 2012 Nov; 36(6):645-62. PubMed ID: 22577120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
    Wilcox MH; Shetty N; Fawley WN; Shemko M; Coen P; Birtles A; Cairns M; Curran MD; Dodgson KJ; Green SM; Hardy KJ; Hawkey PM; Magee JG; Sails AD; Wren MW
    Clin Infect Dis; 2012 Oct; 55(8):1056-63. PubMed ID: 22784871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current advances related to Clostridium difficile infection.
    Kim YG; Jang BI
    Indian J Med Res; 2015 Feb; 141(2):172-4. PubMed ID: 25900952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventing downstream Clostridium difficile infections with upstream antibiotic management.
    Malkan AD; Scholand SJ
    Med Hypotheses; 2012 Jan; 78(1):136-7. PubMed ID: 22079651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians.
    Bakken JS; Polgreen PM; Beekmann SE; Riedo FX; Streit JA
    Anaerobe; 2013 Dec; 24():20-4. PubMed ID: 24012687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.
    Miller M; Gravel D; Mulvey M; Taylor G; Boyd D; Simor A; Gardam M; McGeer A; Hutchinson J; Moore D; Kelly S
    Clin Infect Dis; 2010 Jan; 50(2):194-201. PubMed ID: 20025526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
    Pepin J
    Clin Infect Dis; 2008 May; 46(10):1493-8. PubMed ID: 18419481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Clostridium difficile on inflammatory bowel disease.
    Ananthakrishnan AN; Binion DG
    Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):589-600. PubMed ID: 20932144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.